NO20021430L - Procedure for Therapeutic Management of Extrauterine Proliferation of Endometrial Tissue, Chronic Pelvic Pain and Ovary Obstruction - Google Patents

Procedure for Therapeutic Management of Extrauterine Proliferation of Endometrial Tissue, Chronic Pelvic Pain and Ovary Obstruction

Info

Publication number
NO20021430L
NO20021430L NO20021430A NO20021430A NO20021430L NO 20021430 L NO20021430 L NO 20021430L NO 20021430 A NO20021430 A NO 20021430A NO 20021430 A NO20021430 A NO 20021430A NO 20021430 L NO20021430 L NO 20021430L
Authority
NO
Norway
Prior art keywords
ovary
obstruction
procedure
pelvic pain
chronic pelvic
Prior art date
Application number
NO20021430A
Other languages
Norwegian (no)
Other versions
NO331198B1 (en
NO20021430D0 (en
Inventor
Juergen Engel
Hilde Riethmueller-Winzen
Ricardo Felberbaum
Klaus Diedrich
Wolfgang KUEPKER
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of NO20021430D0 publication Critical patent/NO20021430D0/en
Publication of NO20021430L publication Critical patent/NO20021430L/en
Publication of NO331198B1 publication Critical patent/NO331198B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20021430A 1999-09-23 2002-03-21 Use of the LHRH antagonist for the manufacture of a drug for therapeutically controlling extrauterine endometrial proliferation, chronic pelvic pain and fallopian tube obstruction NO331198B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15547899P 1999-09-23 1999-09-23
PCT/EP2000/009212 WO2001021194A2 (en) 1999-09-23 2000-09-20 Method for the therapeutic management of endometriosis and fallopian tube obstruction

Publications (3)

Publication Number Publication Date
NO20021430D0 NO20021430D0 (en) 2002-03-21
NO20021430L true NO20021430L (en) 2002-05-07
NO331198B1 NO331198B1 (en) 2011-10-31

Family

ID=22555601

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021430A NO331198B1 (en) 1999-09-23 2002-03-21 Use of the LHRH antagonist for the manufacture of a drug for therapeutically controlling extrauterine endometrial proliferation, chronic pelvic pain and fallopian tube obstruction

Country Status (22)

Country Link
EP (1) EP1214086A2 (en)
JP (2) JP2003509467A (en)
KR (1) KR100772852B1 (en)
CN (2) CN1376070A (en)
AU (1) AU769482B2 (en)
BG (1) BG66128B1 (en)
BR (1) BR0014198A (en)
CA (1) CA2383510A1 (en)
HK (1) HK1049117A1 (en)
HU (1) HUP0202741A3 (en)
IL (1) IL148185A0 (en)
MX (1) MXPA02002436A (en)
NO (1) NO331198B1 (en)
NZ (1) NZ534836A (en)
PL (1) PL201898B1 (en)
RU (1) RU2255759C2 (en)
SK (1) SK3752002A3 (en)
TR (1) TR200200738T2 (en)
TW (1) TWI267373B (en)
UA (1) UA73956C2 (en)
WO (1) WO2001021194A2 (en)
ZA (1) ZA200201374B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10157628A1 (en) * 2001-11-26 2003-06-12 Zentaris Ag Solution for injection of an LHRH antagonist
US7214662B2 (en) 2001-11-27 2007-05-08 Zentaris Gmbh Injectable solution of an LHRH antagonist
WO2009094634A1 (en) 2008-01-24 2009-07-30 Esperance Pharmaceuticals Lytic domain fusion constructs and methods of making and using same
CA2750582A1 (en) * 2009-01-22 2010-07-29 Maatschap Interne Geneeskunde Rijnstate Method for the prophylaxis or treatment of flushing
KR20210090298A (en) 2012-10-30 2021-07-19 에스퍼란스 파마슈티컬스, 인코포레이티드 Antibody/drug conjugates and methods of use
EP4223298A3 (en) 2013-03-15 2023-08-16 AbbVie Inc. Compositions for use in treating heavy menstrual bleeding
SG11202001436YA (en) 2017-08-18 2020-03-30 Abbvie Inc Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
TW201912157A (en) 2017-08-18 2019-04-01 美商艾伯維有限公司 Solid pharmaceutical formulation for the treatment of endometriosis, uterine fibroids, polycystic ovary syndrome and adenomyosis
US11690854B2 (en) 2018-04-19 2023-07-04 Abbvie Inc. Methods of treating heavy menstrual bleeding
EP3560555A1 (en) 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064939A (en) * 1990-02-06 1991-11-12 The Salk Institute For Biological Studies Cyclic gnrh antagonists
SE9301606D0 (en) * 1993-05-07 1993-05-07 Per-Christer Oden COMPOSITION FOR THE TREATMENT OF IMPAIRED HAIR GROWTH
US5658884A (en) * 1994-07-22 1997-08-19 The Medical College Of Hampton Roads Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
WO1996003138A1 (en) * 1994-07-22 1996-02-08 The Medical College Of Hampton Roads Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
DE19513662A1 (en) * 1995-04-08 1996-10-10 Schering Ag Combined pharmaceutical preparation for hormonal contraception
DE19604231A1 (en) * 1996-01-29 1997-07-31 Schering Ag Combined pharmaceutical preparation and its use for the treatment of gynecological disorders
RU2108583C1 (en) * 1996-07-29 1998-04-10 Николай Владимирович Рымашевский Method for determining indications to applying hormone therapy in genital endometriosis patients
CN1228708A (en) * 1996-09-04 1999-09-15 有限会社多特 Peptide-containing drug compositions for oral administration
EP0986550A1 (en) * 1997-06-05 2000-03-22 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
DE19911771B4 (en) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH antagonist, process for its preparation and its use

Also Published As

Publication number Publication date
KR100772852B1 (en) 2007-11-02
CA2383510A1 (en) 2001-03-29
NO331198B1 (en) 2011-10-31
JP2012051920A (en) 2012-03-15
NZ534836A (en) 2007-07-27
HUP0202741A3 (en) 2003-12-29
PL201898B1 (en) 2009-05-29
KR20020035879A (en) 2002-05-15
JP2003509467A (en) 2003-03-11
IL148185A0 (en) 2002-09-12
AU7779200A (en) 2001-04-24
NO20021430D0 (en) 2002-03-21
PL353244A1 (en) 2003-11-03
BG106584A (en) 2003-02-28
CN1376070A (en) 2002-10-23
SK3752002A3 (en) 2003-06-03
WO2001021194A3 (en) 2002-03-14
EP1214086A2 (en) 2002-06-19
TR200200738T2 (en) 2002-08-21
TWI267373B (en) 2006-12-01
ZA200201374B (en) 2002-10-30
WO2001021194A2 (en) 2001-03-29
BR0014198A (en) 2002-05-21
MXPA02002436A (en) 2003-02-12
UA73956C2 (en) 2005-10-17
BG66128B1 (en) 2011-06-30
AU769482B2 (en) 2004-01-29
HK1049117A1 (en) 2003-05-02
RU2255759C2 (en) 2005-07-10
HUP0202741A2 (en) 2003-01-28
CN101045155A (en) 2007-10-03

Similar Documents

Publication Publication Date Title
EE200100603A (en) Treatment of human refractory tumors with epidermal growth factor receptor antagonists
NO20021400L (en) Therapeutic quinazoline derivatives
AU2002351397A8 (en) Systems and methods using vasoconstriction for improved thermal treatment of tissues
EP1425277B8 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
AU2001280440A1 (en) Treatment of human herpesviruses using hyperthermia
NO20042208L (en) Vaginally administered anti-dysrhythmic agents for the treatment of pelvic pain
DE59906118D1 (en) COATED MEDICAL DEVICES AND IMPLANTS
NO20021094L (en) Prophylactic and therapeutic drugs for ophthalmic diseases
AU6062900A (en) Substituted indole compounds and their use for the treatment of cancer
HU0002509D0 (en) Combination therapy for treatment of migraine
IL148185A0 (en) Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
SI1173179T1 (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent major depressive disorders
IL130171A0 (en) Therapeutic use of melatonin
NO20020784D0 (en) Medication for the treatment of fractures
IL144115A0 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
HU0002508D0 (en) Combination therapy for treatment of migraine
HUP0001891A2 (en) Medicament for the treatment of migraine
AU1405001A (en) Treatment of diseases
NO20014476D0 (en) Treatment of hiatial hernia
ES1043751Y (en) VIBRATORY TABLE OF THERAPEUTIC EFFECTS.
SI1303306T1 (en) Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure
IT1311582B1 (en) ORTHOPEDIC ORTHOSIS FOR THE TREATMENT OF EPICONDYLITES.
DK199900219U3 (en) Chiropractic treatment and side-bed treatment table
IL126778A0 (en) Administration of histamine for therapeutic purposes

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees